|
|
 |
|
Viewing report
|
|
|
|
Ion Channels and G Protein-coupled Receptors (GPCRs) Qualitative and Quantitative Analysis
Drug and Market Development Publishing, Aug 2006, Pages: 100
This report focuses on two key pharmaceutical target classes-GPCRs and Ion Channels. GPCRs and Ion Channels are important targets. They are associated with a number of disease areas and are currently associated with blockbuster pharmaceutical sales status.
Identifying future direction of industry growth opportunities in these spaces can be challenging. This report characterizes the opportunity in the GPCR and Ion Channel spaces with respect to the following metrics:
- Technologies for interrogation
- Major Products on the market
- Vendors in the space
- Market opportunity, size, and growth (both qualitative and quantitative)
This report draws upon a proprietary end-user survey to assess both the qualitative and quantitative market opportunity in the GPCRs and Ion Channels spaces. The raw data and annotations of these data are presented in this industry report and provide a snapshot into the direction of this market. This report also includes a SWOT analysis of the key market participants, which serves to complement the qualitative and quantitative analysis by offering a glimpse into the scope of opportunity in various niches.
Buy this report and:
- Identify qualitative trends-market drivers, market challenges, bottlenecks, opportunities-in the GPCRs and Ion Channels market segments
- Examine thorough quantitative analysis: market size, market shares of the various companies/technologies, and a cost per assay point, screening metrics
- Gain insight into growth opportunities for tools developers to develop reagents, technologies, hardware/instrumentation to address the growth in the GPCR and Ion Channels spaces
About the Author
Dr. Enal Razvi is currently biotechnology business development consultant based in the San Francisco Bay Area. In this capacity, Dr. Razvi analyzes a number of different market spaces in biotechnology, and assists start-up companies in business development, sales, marketing, and commercialization operations in the San Francisco Bay Area. Previously, Dr. Razvi served as Vice President of Business Development at DiscoveRx Corporation in Fremont, California. Before DiscoveRx, at LJL BioSystems (Sunnyvale, CA), Dr. Razvi served as Senior Director of Business Development and played a major role in developing LJL BioSystems' SNP genotyping business. Subsequent to the acquisition of LJL BioSystems by Molecular Devices Corporation, Dr. Razvi ran Molecular Devices' Genomics business. Prior to LJL, while at Frost & Sullivan, Dr. Razvi served as Director of their Drug Discovery Consulting business. Dr. Razvi holds a doctorate in biomedical sciences from the University of Massachusetts Medical School, and completed post-doctoral work at The Rockefeller University in New York and at Harvard Medical School.
Customers who bought this item also bought
GPCR - Drug Targets
Market Opportunity in the G-Protein Coupled Receptors (GPCRs) Target Space: Qualitative and Quantitative Market Metrics
G-Protein Coupled Receptors (GPCRs) 2007 Market Report
G-Protein Coupled Receptors (GPCRs): Technical Overview, Emerging Technologies, Market Trends & Opportunities, 2nd Edition
Ion Channels: Technology Advances Driving Commercial Opportunities
Structure, Function and Modulation of Neuronal Voltage-Gated Ion Channels
Ion Channel Assays in the Drug Discovery Process
Gpcrs: The Targets of Today's Drugs and Tomorrow's Blockbusters
Assay Development and Technologies, 2nd Edition
Promising New Approaches for Discovering Ion-Channel Modulators
The 2009-2014 World Outlook for Ion Implantation and Current and Voltage Ion Implanters
The 2009 Report on Ion Implantation and Current and Voltage Ion Implanters: World Market Segmentation by City
|
|
|
|
